Mesozeaxanthin formulations for treatment of retinal disorders
US6329432A · kind A · utility
25Cited by
4References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2001 |
| Grant date | Dec 11, 2001 |
| Priority date | — |
| Expiry date | Mar 2, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Meso-zeaxanthin compositions for pharmaceutical use and use of meso-zeaxanthin to increase the deposition of macular pigment in the human eye, and for the therapeutic treatment or prophylaxis of diseases and disorders of the macula, in particular age-related macular degeneration (AMD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.